ANTHEM BIOSCIENCES
Back to Income Statement
|
ANTHEM BIOSCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,124 Cr | ₹1,845 Cr | ₹1,419 Cr | ₹1,057 Cr | ₹1,231 Cr |
What is the latest Revenue of ANTHEM BIOSCIENCES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹2,124 Cr |
| Mar2025 | ₹1,845 Cr |
| Mar2024 | ₹1,419 Cr |
| Mar2023 | ₹1,057 Cr |
| Mar2022 | ₹1,231 Cr |
How is Revenue of ANTHEM BIOSCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,124 Cr | 15.17 | |
| Mar2025 | ₹1,845 Cr | 29.96 | |
| Mar2024 | ₹1,419 Cr | 34.29 | |
| Mar2023 | ₹1,057 Cr | -14.16 | |
| Mar2022 | ₹1,231 Cr | - | |
Compare Revenue of peers of ANTHEM BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANTHEM BIOSCIENCES | ₹42,102.9 Cr | -2.6% | -4.2% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
ANTHEM BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANTHEM BIOSCIENCES | -2.6% |
-4.2% |
|
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses